David M. Joyner, M.D., a former chairman and senior member of the United States Olympic Committee sports medicine team, will put his talents to work as senior vice president and executive director of the Andrews Institute. The Andrews Institute was founded by internationally renowned orthopedic surgeon, James Andrews, M.D.
David M. Joyner, M.D. Now Senior VP at Andrews Institute

Dr. Joyner was most recently the athletic director for Penn State University and a member of the Penn State University Board of Trustees. He told OTW, “I am honored to be part of such a renowned organization that provides orthopaedic and sports medicine care to everyone from elite athletes that travel the globe to receive care here to residents in our own backyard in Gulf Breeze, Florida. We work hard to apply the same sports medicine principals to all of our patients, whether they are a goalie, gardener or grandpa.”
“As a new member of the leadership team, I will explore opportunities moving forward where we can continue to improve. We always focus on providing the best patient care, as well as advancing the science of orthopaedics and sports medicine through research and education. Applying evidence-based medicine directly to patient care is what we do, and improving that process in a safe and efficient manner is how we will continue to provide best-in-class patient outcomes.”
Asked about his plans for strategic business partnerships/affiliations or recruitment, Dr. Joyner added, “While we already have a highly selective and competitive process for partnerships, affiliations and recruitment, I will work with other members of the Andrews Institute and Pensacola-based Baptist Health Care leadership teams to enhance the care we provide, and where appropriate, will look seriously at strategic alignments.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.